M.D.C. (MDC) Updated to "Neutral" by JPMorgan Chase & Co.

Business



[ad_1]

M.D.C. logo "title =" M.D.C. logo "classc" companylogo "/> <span> MDC (NYSE: MDC) </span> has been improved by analysts of JPMorgan Chase & Co. from an" underweighted "rating to a" neutral "rating in a report released Friday, July 13, Marketbeat Ratings reports that the brokerage company currently has a price target of $ 36.00 on the shares of the construction company, and that JPMorgan Chase & Jr.'s price target Co. would suggest a potential upside of 24.44% UBS Group republished a "buy" rating and issued a price target of $ 35.00 (previously $ 32.00) on MDC shares in a report released on December 31 Friday, May 4, 2009. Wedbush reaffirms a "neutral" rating On Friday, May 4, Zelman & Associates took MDC shares from a "hold" rating to a "buy" rating in a report on Friday, May 4, on a $ 30.00 price (previously $ 33.00) .ValuEngine cut hold of MDC shares of a "hold Finally, Raymond James confirmed a note "Purchase" and issued a target price of $ 39.00 (previously $ 35.00) on the shares of M.D.C. in a research report on Tuesday, May 8th. Three equity research analysts evaluated the stock with a sales note, seven assigned a reserve rating and three assigned a buy-to-action rating of the company. M.D.C. currently has an average rating of "Hold" and a consensus target price of $ 34.00. </p> <p> NYSE Shares: MDC open at $ 28.93 on Friday. The company has a ratio of 2.68, a ratio of 9.79 and a debt ratio of 0.75. M.D.C. has a twelve-month low of $ 26.45 and a twelve-month high of $ 37.45. The company has a market capitalization of $ 1.63 billion, a price / earnings ratio of 11.21, a price / earnings ratio of 0.49 and a beta of 1.45. </p> <p> M.D.C. (NYSE: MDC) last announced its quarterly earnings data on Thursday, May 3rd. The construction company reported earnings per share of $ 0.68 for the quarter, exceeding the consensus estimate of $ 0.53 per $ 0.15. During the quarter, the company achieved a turnover of $ 607.69 million, against $ 584.58 million for analysts. M.D.C. had a net margin of 6.04% and a return on equity of 11.99%. The quarterly business turnover of the company is up 7.8% over the same quarter of last year. During the same period of the previous year, the company posted earnings per share of $ 0.40. Equity research analysts predict that M.D.C. will show 3.41 results per share for the current fiscal year. </p> <p> In addition, Chief Financial Officer Robert Nathaniel Martin sold 9,000 shares of the stock during a transaction that occurred on Tuesday, May 8. The stock was sold at an average price of $ 31.91, for a total value of $ 287,190.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed via this hyperlink. In addition, director David E. Blackford sold 2,144 shares in a transaction on Friday, May 4. The shares were sold at an average price of $ 32.51, for a total value of $ 69,701.44. The disclosure for this sale can be found here. Insiders sold 217,819 shares valued at $ 6,972,993 during the last quarter. 27.00% of the stock is currently held by insiders. </p> <p> Hedge funds recently bought and sold shares in the company. Nisa Investment Advisors LLC has raised its holdings of M.D.C. 5.5% in the second quarter. Nisa Investment Advisors LLC now holds 34,766 shares in the $ 1,070,000 construction business after the purchase of 1,800 additional shares during the period. Amalgamated Bank acquired a new stake in M.D.C. during the second quarter, worth $ 204,000. Baltimore Capital Management Inc. has raised its holdings of M.D.C. 14.5% in the second quarter. Baltimore Capital Management Inc. now holds 50,575 shares in the construction business worth $ 1,556,000 after the purchase of 6,400 additional shares during the period. Smith Graham & Co. Investment Advisors LP acquired a new interest in M.D.C. in the second quarter worth $ 7,530,000. Finally, Dynamic Technology Private Lab Ltd has acquired a new stake in M.D.C. in the first quarter worth $ 335,000. 78.55% of the capital is held by institutional investors and hedge funds. </p> <p> <strong> About M.D.C. </strong> </p> <p> Mr. DC Holdings, Inc., through its subsidiaries, operates in the areas of residential construction and financial services. Its homebuilding activities include the purchase of finished lots or the development of lots for the construction and sale primarily of single-family homes to first-time homebuyers and under the name of Richmond American Homes. </p> <p> See also: <br /><!--ViewCount:type=a&id=1051424--></p> <p style= Analyst Recommendations for MDC (NYSE: MDC)

Receive News and Reviews for MDC Daily – Enter your email address below to receive a concise summary Daily breaking news and analyst ratings for MDC and related companies with MarketBeat.com's free daily e-newsletter.

[ad_2]
Source link

Tags

Powered by https://naaju.com/zimbabwe | Designed by Naaju
© Copyright 2024, All Rights Reserved